Clinical Trials suffer due to inherent inefficiencies in manual workflows built on fragmented systems. It's time for a ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
A recent study found that up to 40% of trials might be untrustworthy due to flaws in design, improper data collection, and ...
NIH updates clinical trial definition to exclude basic experimental studies involving humans from clinical trial requirements starting May 2026.
A major challenge in the clinical trial space is ensuring a diverse group of patients enrolls in the program. | A major ...
AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate them.
Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options, but are an important part of cancer care at every stage and most aspects ...
Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...
Conflict of interest reporting is flawed and inconsistent across clinical trials assessing the effectiveness of corticosteroid injections in knee osteoarthritis, according to data published in ...
PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic diseaseCarmel Nanthakumar, ...
Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...
The trouble with FDA's move to require only one study for new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results